Peroxisome proliferator-activated receptor γ polymorphisms affect systemic inflammation and survival in end-stage renal disease patients starting renal replacement therapy - Yao, Q.; Nordfors, L.; Axelsson, J.; Heimbürger, O.; Qureshi, A.R.; Báràny, P.; Lindholm, B.; Lönnqvist, F.; Schalling, M.; Stenvinkel, P. (Atherosclerosis (00219150), 2005)